Product Images Etoposide

This is a caution about the use of a cytotoxic agent, Etoposide Injection USP, contained in a 12.5 mL multiple dose vial. The vial is manufactured by Accord B and TAT Intas Pharmaceuticals Limited. It must be diluted before IV infusion and has specific dosage instructions that can be found in the accompanying circular. The injection is made up of several components and must be stored at a USP controlled room temperature range of 20°:25°C (68%77°F).*

This is a label for Etoposide Injection USP, a cytotoxic agent that comes in a 25 mL multiple-dose vial, containing 20 mg of etoposide USP per mL. The drug must be diluted before intravenous infusion, and the usual dosage instructions are available in the accompanying circular. The drug is manufactured by Intas Pharmaceuticals Limited in India and is distributed by Accord Healthcare, Inc., in Durham, NC. The label includes disclaimers, such as a warning to keep the area blank and varnish-free for the lot and the expiration date. The drug should be stored between 20°C and 25°C.*

This is a label for Etoposide Injection USP, a cytotoxic agent, manufactured by Accord Healthcare. The medication is available in a 50 mL multiple dose vial, with each 1 mL containing 20 mg of etoposide. The label warns to keep the area of the label blank and varnish-free to facilitate overcoding lot and expiration information. It also includes the National Drug code, the dosage, and the cautionary instructions regarding usage and storage.*

This appears to be a label for a medication called Etoposide, in injection form. It is a cytotoxic agent that must be diluted before use, and caution must be used. The medication is manufactured by Accord Healthcare, Inc. The label also provides information on dosage and storage.*